U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Research & Early Development Digital Academy Lead

Learning & DevelopmentUpdated on Nov 14
Full-timeNo salary listed

About the Job

Requirements

  • Strong experience in learning experience design, capability development, product management, platform ownership, or change enablement.
  • Ability to translate capability frameworks and workforce needs into practical learning experiences and development pathways.
  • Strong understanding of scientific roles, workflows, and capability needs within a research environment.
  • Excellent communication, branding, and stakeholder management skills.
  • Comfortable owning complex, cross-cutting initiatives end-to-end.
  • Experience working across learning, transformation, talent, or organisational development initiatives.

Responsibilities

  • Define and evolve the learning strategy for Research & Early Development, translating capability and workforce needs into role-based learning pathways and development experiences.
  • Lead and grow a portfolio of academies, ensuring alignment with organisational priorities and expanding offerings to address emerging capability requirements.
  • Design engaging learner journeys that progress learners from awareness through application, delivering practical and impactful capability development.
  • Build and lead a community of Academy Champions, leveraging peer networks to enhance learning, mentoring, adoption, and content quality.
  • Oversee content strategy and curation, ensuring learning resources are relevant, high quality, and organised into coherent learning experiences.
  • Drive Academy engagement, communications, and brand visibility, establishing a compelling value proposition and fostering a culture of continuous learning.
  • Own Academy governance, platform experience, and impact measurement, ensuring effective operations, strong learner experiences, and continuous improvement through adoption, feedback, and capability outcomes.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs